SCYNEXIS Confirms that BREXAFEMME® (ibrexafungerp tablets) Qualifies for 10 Years of Regulatory Exclusivity for Vaginal Yeast Infections

by NASDAQ Market News June 9, 2021

NASDAQ Market News
Click here to email author

Dermatology Drugs Market 2021-Global Industry Share, Size, Growth, Demands, Revenue, Top Leaders and Healthy Growth Rate at 9.75% up to 2028

BriaCell to Host Corporate and Clinical Update Conference Call Wednesday, June 16, 2021 at 4:30 p.m. ET

Ads